Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling.
暂无分享,去创建一个
Francine E. Garrett-Bakelman | S. Lowe | O. Abdel-Wahab | R. Levine | M. Tallman | T. Baslan | H. Lazarus | E. Paietta | J. Racevskis | J. Rowe | Zhuoxin Sun | Yanming Zhang | S. Luger | R. Ketterling | C. Ganzel | M. Litzow | H. Fernandez | GonenMithat Gönen | R. Levine